Suppr超能文献

腹主动脉肠瘘血管内支架修复术后的结局:一项系统评价

Outcome after endovascular stent graft repair of aortoenteric fistula: A systematic review.

作者信息

Antoniou George A, Koutsias Stylianos, Antoniou Stavros A, Georgiakakis Andreas, Lazarides Miltos K, Giannoukas Athanasios D

机构信息

Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, Larissa, Greece.

出版信息

J Vasc Surg. 2009 Mar;49(3):782-9. doi: 10.1016/j.jvs.2008.08.068. Epub 2008 Nov 22.

Abstract

BACKGROUND

Aortoenteric fistula (AEF) is a critical clinical condition, which may present with gastrointestinal hemorrhage, with or without signs of sepsis. Conventional open surgical repair is associated with high morbidity and mortality. Endovascular stent graft repair has been attempted, but recurrent infection remains of major concern. We conducted a systematic review to assess potential factors associated with poor outcome after endovascular treatment.

METHODS

The English literature was searched using the MEDLINE electronic database up to April 2008. All studies reporting on the primary management of primary or secondary AEF with endovascular stent graft repair were considered.

RESULTS

Data were extracted from 33 reports that included 41 patients and were entered in the final analysis. Persistent/recurrent/new infection or recurrent hemorrhage developed in 44% of the patients, after a mean follow-up period of 13 months (range, 0.13-36). Secondary, as compared to primary, AEF had an almost threefold increased risk of persistent/recurrent infection. Evidence of sepsis preoperatively was found to be a factor indicating unfavorable outcome (P < .05). Persistent/recurrent/new infection after treatment was associated with worse 30-day and overall survival compared with those who did not develop sepsis (P < .05).

CONCLUSION

Endovascular stent graft repair of AEF was associated with a high incidence of infection or recurrent bleeding postoperatively. Evidence of sepsis preoperatively was indicating poor outcome.

摘要

背景

主动脉肠瘘(AEF)是一种危急的临床病症,可能表现为胃肠道出血,伴有或不伴有败血症迹象。传统的开放手术修复与高发病率和死亡率相关。已经尝试进行血管内支架植入修复,但反复感染仍然是主要关注点。我们进行了一项系统评价,以评估血管内治疗后与不良结局相关的潜在因素。

方法

使用MEDLINE电子数据库检索截至2008年4月的英文文献。纳入所有报道采用血管内支架植入修复原发性或继发性AEF的初始治疗的研究。

结果

从33篇报道中提取数据,这些报道包括41例患者,并纳入最终分析。在平均随访13个月(范围0.13 - 36个月)后,44%的患者出现持续/复发/新发感染或反复出血。与原发性AEF相比,继发性AEF发生持续/复发感染的风险几乎增加了两倍。术前存在败血症迹象被发现是提示不良结局的一个因素(P <.05)。与未发生败血症的患者相比,治疗后出现持续/复发/新发感染的患者30天和总体生存率更差(P <.05)。

结论

AEF的血管内支架植入修复与术后高感染率或反复出血相关。术前存在败血症迹象提示预后不良。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验